Pentadecapeptide BPC 157 attenuates gastric lesions induced by alloxan in rats and mice.
J Physiol Paris
; 93(6): 501-4, 1999 Dec.
Article
en En
| MEDLINE
| ID: mdl-10672996
ABSTRACT
A diabetogenic alloxan regimen produced lesions in all stomachs of treated animals, either rats (200 mg x kg(-1) s.c.) or mice (400 mg x kg(-1) i.p.). In control animals, the lesions, when developed (i.e. 24 h following application), appear to be quite sustained, and consistently present also after 1 or 2 weeks. The application of the pentadecapeptide BPC 157 (10 microg or 10 ng x kg(-1) i.p. coadministered together with alloxan) would significantly attenuate these lesions' appearance. This beneficial effect seems to be present in either rats or mice and in either of the tested intervals. Importantly, the beneficial effect seems to be shared by both microgram and nanogram regimens.
Buscar en Google
Bases de datos:
MEDLINE
Asunto principal:
Fragmentos de Péptidos
/
Úlcera Gástrica
/
Proteínas
/
Aloxano
/
Mucosa Gástrica
/
Antiulcerosos
Límite:
Animals
Idioma:
En
Revista:
J Physiol Paris
Asunto de la revista:
FISIOLOGIA
Año:
1999
Tipo del documento:
Article
País de afiliación:
Croacia